Ad is loading...
COCP
Price
$2.15
Change
+$0.09 (+4.37%)
Updated
Nov 21 closing price
CYTK
Price
$49.57
Change
+$1.90 (+3.99%)
Updated
Nov 22, 12:51 PM (EDT)
90 days until earnings call
Ad is loading...

COCP vs CYTK

Header iconCOCP vs CYTK Comparison
Open Charts COCP vs CYTKBanner chart's image
Cocrystal Pharma
Price$2.15
Change+$0.09 (+4.37%)
Volume$18.69K
CapitalizationN/A
Cytokinetics
Price$49.57
Change+$1.90 (+3.99%)
Volume$764
CapitalizationN/A
COCP vs CYTK Comparison Chart
Loading...
COCP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CYTK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
COCP vs. CYTK commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COCP is a StrongSell and CYTK is a StrongBuy.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (COCP: $2.15 vs. CYTK: $47.67)
Brand notoriety: COCP and CYTK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COCP: 92% vs. CYTK: 146%
Market capitalization -- COCP: $21.87M vs. CYTK: $5.88B
COCP [@Biotechnology] is valued at $21.87M. CYTK’s [@Biotechnology] market capitalization is $5.88B. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COCP’s FA Score shows that 0 FA rating(s) are green whileCYTK’s FA Score has 1 green FA rating(s).

  • COCP’s FA Score: 0 green, 5 red.
  • CYTK’s FA Score: 1 green, 4 red.
According to our system of comparison, CYTK is a better buy in the long-term than COCP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COCP’s TA Score shows that 5 TA indicator(s) are bullish while CYTK’s TA Score has 2 bullish TA indicator(s).

  • COCP’s TA Score: 5 bullish, 5 bearish.
  • CYTK’s TA Score: 2 bullish, 8 bearish.
According to our system of comparison, COCP is a better buy in the short-term than CYTK.

Price Growth

COCP (@Biotechnology) experienced а -2.27% price change this week, while CYTK (@Biotechnology) price change was -12.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.74%. For the same industry, the average monthly price growth was -7.78%, and the average quarterly price growth was +1.53%.

Reported Earning Dates

COCP is expected to report earnings on May 15, 2023.

CYTK is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (-3.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($5.88B) has a higher market cap than COCP($21.9M). COCP YTD gains are higher at: 24.840 vs. CYTK (-42.903). COCP has higher annual earnings (EBITDA): -20.31M vs. CYTK (-481.94M). CYTK has more cash in the bank: 1.01B vs. COCP (13M). COCP has less debt than CYTK: COCP (1.88M) vs CYTK (790M). CYTK has higher revenues than COCP: CYTK (3.22M) vs COCP (0).
COCPCYTKCOCP / CYTK
Capitalization21.9M5.88B0%
EBITDA-20.31M-481.94M4%
Gain YTD24.840-42.903-58%
P/E RatioN/AN/A-
Revenue03.22M-
Total Cash13M1.01B1%
Total Debt1.88M790M0%
FUNDAMENTALS RATINGS
COCP vs CYTK: Fundamental Ratings
COCP
CYTK
OUTLOOK RATING
1..100
6972
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
10051
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
5153
P/E GROWTH RATING
1..100
991
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

COCP's Valuation (70) in the Pharmaceuticals Generic industry is in the same range as CYTK (100) in the Biotechnology industry. This means that COCP’s stock grew similarly to CYTK’s over the last 12 months.

CYTK's Profit vs Risk Rating (51) in the Biotechnology industry is somewhat better than the same rating for COCP (100) in the Pharmaceuticals Generic industry. This means that CYTK’s stock grew somewhat faster than COCP’s over the last 12 months.

COCP's SMR Rating (98) in the Pharmaceuticals Generic industry is in the same range as CYTK (100) in the Biotechnology industry. This means that COCP’s stock grew similarly to CYTK’s over the last 12 months.

COCP's Price Growth Rating (51) in the Pharmaceuticals Generic industry is in the same range as CYTK (53) in the Biotechnology industry. This means that COCP’s stock grew similarly to CYTK’s over the last 12 months.

CYTK's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for COCP (99) in the Pharmaceuticals Generic industry. This means that CYTK’s stock grew significantly faster than COCP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COCPCYTK
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
74%
Advances
ODDS (%)
Bullish Trend 9 days ago
83%
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 1 day ago
76%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
75%
View a ticker or compare two or three
Ad is loading...
COCP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CYTK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NXTE32.460.41
+1.27%
AXS Green Alpha ETF
RLY28.730.15
+0.52%
SPDR® SSgA Multi-Asset Real Return ETF
SPRE21.010.08
+0.39%
SP Funds S&P Global REIT Sharia ETF
PSIL11.91-0.10
-0.82%
AdvisorShares Psychedelics ETF
TSLL20.83-0.31
-1.47%
Direxion Daily TSLA Bull 2X Shares

COCP and

Correlation & Price change

A.I.dvisor indicates that over the last year, COCP has been loosely correlated with FATE. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if COCP jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COCP
1D Price
Change %
COCP100%
+4.37%
FATE - COCP
34%
Loosely correlated
-6.76%
VKTX - COCP
31%
Poorly correlated
+0.19%
BYSI - COCP
28%
Poorly correlated
+1.75%
ALZN - COCP
27%
Poorly correlated
-0.76%
CYTK - COCP
27%
Poorly correlated
-4.39%
More